| meta-analysis | Q815382 |
| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Martin P | |
| Fabrizi F | |||
| Dixit V | |||
| Bunnapradist S | |||
| Dulai G | |||
| P2860 | cites work | Meta-analysis in clinical trials | Q27860779 |
| Effects of hepatitis C infection and renal transplantation on survival in end-stage renal disease. The New England Organ Bank Hepatitis C Study Group | Q33464499 | ||
| Cancer in patients on dialysis for end-stage renal disease: an international collaborative study | Q33845510 | ||
| Hepatitis C infection and the patient with end-stage renal disease | Q34708264 | ||
| Host defenses and immunologic alterations associated with chronic hemodialysis | Q40293998 | ||
| Histopathological features of hepatitis C in renal transplant candidates [see comment] | Q41734319 | ||
| Liver disease in dialysis patients with antibodies to hepatitis C virus | Q42980491 | ||
| Risk of death and liver cirrhosis in anti-HCV-positive long-term haemodialysis patients | Q43033231 | ||
| Liver disease patterns in hemodialysis patients with antibodies to hepatitis C virus | Q43035235 | ||
| Hepatitis C virus infection in renal failure patients in the absence of anti-hepatitis C virus antibodies | Q43036910 | ||
| Quantitation of hepatitis C viral RNA in sera of hemodialysis patients: gender-related differences in viral load | Q43041859 | ||
| The retrieval of randomized clinical trials in liver disease from the medical literature. A comparison of MEDLARS and manual methods | Q43842087 | ||
| Chronic hepatitis C infection in patients with end stage renal disease: characterization of liver histology and viral load in patients awaiting renal transplantation | Q44866858 | ||
| National surveillance of dialysis-associated diseases in the United States, 2001. | Q51647558 | ||
| P433 | issue | 11-12 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | hepatitis C | Q154869 |
| meta-analysis | Q815382 | ||
| renal dialysis | Q202301 | ||
| Hepatitis C virus | Q708693 | ||
| P304 | page(s) | 1271-1277 | |
| P577 | publication date | 2004-12-01 | |
| P1433 | published in | Alimentary Pharmacology & Therapeutics | Q4726656 |
| P1476 | title | Meta-analysis: Effect of hepatitis C virus infection on mortality in dialysis | |
| P478 | volume | 20 |
| Q35072818 | A study of the immunoloregulation of double filtration plasmapheresis in maintenance hemodialysis patients with chronic hepatitis C. |
| Q42987891 | Adacolumn treatment in kidney transplant patients with hepatitis C virus. |
| Q42251188 | Age and gender differences in the relationship between hepatitis C infection and all stages of Chronic kidney disease |
| Q50556069 | Anti-viral therapy in haemodialysed HCV patients: efficacy, tolerance and treatment strategy. |
| Q31126057 | Causal inference regarding infectious aetiology of chronic conditions: a systematic review |
| Q33386956 | Clinical significance of alanine aminotransferase levels and the effect of ursodeoxycholic acid in hemodialysis patients with chronic hepatitis C. |
| Q35985941 | Effect of dialysis modality on survival of hepatitis C-infected ESRF patients |
| Q35012447 | Effect of kidney transplantation on outcomes among patients with hepatitis C |
| Q42206661 | Efficacy and safety of hepatitis C antiviral therapy in moderate and severe chronic kidney disease. |
| Q37697588 | Efficacy and tolerability of low-dose interferon-α in hemodialysis patients with chronic hepatitis C virus infection |
| Q41921995 | Epidemiology of hepatitis C virus among hemodialysis patients in the Middle East and North Africa: systematic syntheses, meta-analyses, and meta-regressions |
| Q35507593 | Hepatitis C and hepatitis B seroprevalence and associated risk factors in hemodialysis patients in Guilan province, north of Iran: HCV and HBV seroprevalence in hemodialysis patients |
| Q34966853 | Hepatitis C and kidney disease: An overview and approach to management |
| Q35094769 | Hepatitis C and kidney transplantation |
| Q38017157 | Hepatitis C and renal transplantation |
| Q35237329 | Hepatitis C in hemodialysis patients |
| Q37088857 | Hepatitis C in hemodialysis patients: current global magnitude, natural history, diagnostic difficulties, and preventive measures |
| Q38552198 | Hepatitis C infection and chronic renal diseases |
| Q36606968 | Hepatitis C infection in dialysis patients: a link to poor clinical outcome? |
| Q27009100 | Hepatitis C infection in hemodialysis patients: A review |
| Q36843489 | Hepatitis C is less aggressive in hemodialysis patients than in nonuremic patients |
| Q36496970 | Hepatitis C virus and its renal manifestations: a review and update |
| Q90602898 | Hepatitis C virus infection and chronic renal disease: A review |
| Q40658865 | Hepatitis E Virus Infection Among Chronic Hemodialysis |
| Q51662874 | Hepatitis status and mortality in hemodialysis population. |
| Q64248438 | Hepatitis-C and it's seroconversion in end stage kidney disease patients on maintenance hemodialysis and factors affecting it |
| Q41734101 | Histological features of chronic hepatitis C in haemodialysis patients |
| Q45400047 | Impact of hepatitis C virus infection and other comorbidities on survival in patients on dialysis |
| Q33277945 | Infection by the hepatitis C virus in chronic renal failure patients undergoing hemodialysis in Mato Grosso state, central Brazil: a cohort study. |
| Q35532440 | Infections in hemodialysis: a concise review. Part II: blood transmitted viral infections |
| Q27489433 | Interferon for Hepatitis C Virus in Hemodialysis--an Individual Patient Meta-analysis of Factors Associated with Sustained Virological Response |
| Q24187826 | Interventions for dialysis patients with hepatitis C virus (HCV) infection |
| Q43845256 | Kidney transplantation in hepatitis C-positive recipients: does type of induction influence outcomes? |
| Q37692546 | Lack of Efficacy of Pegylated Interferon Monotherapy for Hepatitis C in Patients With End-Stage Renal Disease on Dialysis |
| Q41925546 | Ledipasvir and Sofosbuvir for untreated HCV genotype 1 infection in end stage renal disease patients: A prospective observational study |
| Q33969758 | Long-term viral negativity after interferon for chronic hepatitis C virus infection in hemodialysis |
| Q36621422 | Lost in publication: Half of all renal practice evidence is published in non-renal journals. |
| Q26821786 | Management of chronic hepatitis C virus infection in patients with end-stage renal disease: a review |
| Q42988519 | Prevalence and risk factors of hepatitis C and B virus infections in hemodialysis patients and their spouses: a multicenter study in Beijing, China |
| Q45384650 | Quality of life in hemodialysis patients: hepatitis C virus infection makes sense |
| Q52564573 | Seroprevalence occurrence of viral hepatitis and HIV among hemodialysis patients. |
| Q45867154 | Should ribavirin be used to treat hepatitis C in dialysis patients? |
| Q45401816 | Simple blood tests as noninvasive markers of liver fibrosis in hemodialysis patients with chronic hepatitis C virus infection |
| Q64940516 | Successful Hepatitis C Virus Eradication in a Hemodialysis Patient With 2k/1b Chimera Genotype: A Case Report and Literature Review. |
| Q36944054 | The impact of hepatitis C virus infection on survival in dialysis patients: meta-analysis of observational studies |
| Q58129215 | The long-term impact of hepatitis C infection in kidney transplantation in the pre-direct acting antiviral era |
| Q43112745 | The ratio of aminotransferase to platelets is a useful index for predicting hepatic fibrosis in hemodialysis patients with chronic hepatitis C. |
| Q34926896 | Transient elastography to assess hepatic fibrosis in hemodialysis chronic hepatitis C patients. |
| Q50558388 | Treatment Uptake of Patients with Chronic Hepatitis C: Can We Expect and Do More? |
| Q64968302 | Update on the Management of Hepatitis C Virus Infection in the Setting of Chronic Kidney Disease and Kidney Transplantation. |
| Q38975165 | Use of direct-acting agents for hepatitis C virus-positive kidney transplant candidates and kidney transplant recipients |
| Q92064867 | Use of sofosbuvir based regimen in patients with end-stage renal disease and chronic hepatitis C; an open label, non-randomized, single arm, single center study from Pakistan |
| Q42272319 | Viral hepatitis in solid organ transplantation |
Search more.